A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents
- PMID: 14645935
- PMCID: PMC1766135
- DOI: 10.1136/tc.12.suppl_4.iv11
A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents
Abstract
Background: This study tested the efficacy of nicotine patches in combination with behavioural therapy for the treatment of adolescent spit tobacco addiction. Prior interventions had resulted in mean cessation rates below 15% at one year.
Methods: This study, the PATCH Project, used a three group, placebo controlled, randomised clinical trial design. The control group received a standard 3-5 minute counselling followed by a two week follow up phone call. The two intervention groups received a six week behavioural intervention; in addition, one group received active nicotine patches while the other group received placebo patches. Both groups received quarterly stage based telephone counselling.
Results: At one year, the usual care group's spit tobacco cessation rate was 11.4% (exact 95% confidence interval (CI) 6.1% to 19.1%), placebo patch 25.0% (95% CI 16.9% to 34.7%), and the active patch 17.3% (95% CI 10.4% to 26.3%). When both patch groups were combined, the cessation rate was 21.2% (95% CI 15.7% to 27.6%). The cessation rates for active and placebo patch were not significantly different (exact two sided p = 0.22), while the combined patch groups had a significantly greater cessation rate than usual care (exact two sided p = 0.04).
Conclusions: The behavioural intervention proved to be about twice as successful as previous interventions, but the nicotine patch offered no improvement in cessation rates. The behavioural intervention is based on publicly available materials and can be easily adapted for widespread use, particularly in high schools.
Similar articles
-
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.Pediatrics. 2005 Apr;115(4):e407-14. doi: 10.1542/peds.2004-1894. Pediatrics. 2005. PMID: 15805342 Clinical Trial.
-
The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.Addiction. 2012 Oct;107(10):1857-67. doi: 10.1111/j.1360-0443.2012.03906.x. Epub 2012 May 17. Addiction. 2012. PMID: 22594651 Clinical Trial.
-
Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.BMC Med. 2016 Jun 7;14:80. doi: 10.1186/s12916-016-0626-2. BMC Med. 2016. PMID: 27233840 Free PMC article. Clinical Trial.
-
A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.Nicotine Tob Res. 2013 Dec;15(12):2037-44. doi: 10.1093/ntr/ntt097. Epub 2013 Jul 19. Nicotine Tob Res. 2013. PMID: 23873976 Free PMC article. Clinical Trial.
-
A comparison of measures used to assess effectiveness of the transdermal nicotine patch at 1 year.Addict Behav. 1997 Nov-Dec;22(6):753-7. doi: 10.1016/s0306-4603(97)00041-5. Addict Behav. 1997. PMID: 9426792 Review.
Cited by
-
Therapy for specific problems: youth tobacco cessation.Annu Rev Psychol. 2009;60:229-55. doi: 10.1146/annurev.psych.60.110707.163659. Annu Rev Psychol. 2009. PMID: 19035825 Free PMC article. Review.
-
Smokeless tobacco cessation interventions: A systematic review.Indian J Med Res. 2018 Oct;148(4):396-410. doi: 10.4103/ijmr.IJMR_1983_17. Indian J Med Res. 2018. PMID: 30666002 Free PMC article.
-
Pharmacological intervention of nicotine dependence.Biomed Res Int. 2013;2013:278392. doi: 10.1155/2013/278392. Epub 2013 Dec 29. Biomed Res Int. 2013. PMID: 24490153 Free PMC article. Review.
-
Pharmacological interventions for the treatment of smokeless tobacco use.CNS Drugs. 2012 Jan 1;26(1):1-10. doi: 10.2165/11598450-000000000-00000. CNS Drugs. 2012. PMID: 22136150 Review.
-
Interventions for smokeless tobacco use cessation.Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD015314. doi: 10.1002/14651858.CD015314.pub2. Cochrane Database Syst Rev. 2025. PMID: 40232040
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous